Okumiya T - Search Results

1

Intravascular hemolysis in patients with mitral regurgitation: Evaluation by erythrocyte creatine.

Sugiura T, Okumiya T, Kamioka M, Kubo T, Hirakawa Y, Hisahara T, Matsumura Y. Sugiura T, et al. Among authors: okumiya t. J Cardiol. 2018 Apr;71(4):414-418. doi: 10.1016/j.jjcc.2017.10.006. Epub 2017 Nov 22. J Cardiol. 2018. PMID: 29174597 Free article.

2

Evaluation of intravascular hemolysis with erythrocyte creatine in patients with cardiac valve prostheses.

Okumiya T, Ishikawa-Nishi M, Doi T, Kamioka M, Takeuchi H, Doi Y, Sugiura T. Okumiya T, et al. Chest. 2004 Jun;125(6):2115-20. doi: 10.1378/chest.125.6.2115. Chest. 2004. PMID: 15189930

3

Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Kubo T, Okumiya T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Sugiura T, Doi YL, Kitaoka H. Kubo T, et al. Among authors: okumiya t. J Cardiol. 2016 Mar;67(3):274-8. doi: 10.1016/j.jjcc.2015.05.005. Epub 2015 Aug 4. J Cardiol. 2016. PMID: 26254020 Free article.

4

Evaluation of Intravascular Hemolysis With Erythrocyte Creatine in Patients With Aortic Stenosis.

Sugiura T, Okumiya T, Kubo T, Takeuchi H, Matsumura Y. Sugiura T, et al. Among authors: okumiya t. Int Heart J. 2016 Jul 27;57(4):430-3. doi: 10.1536/ihj.15-433. Epub 2016 Jun 29. Int Heart J. 2016. PMID: 27357437 Free article.

5

HbA1c adjusted by erythrocyte creatine is a useful glycemic control indicator in patients with hemolysis.

Koga M, Inada S, Shibata M, Ijima H, Jinnouchi H, Ono Y, Iwasaka T, Tokuhiro S, Matsumura Y, Matsui H, Okumiya T. Koga M, et al. Among authors: okumiya t. Clin Biochem. 2019 Nov;73:77-81. doi: 10.1016/j.clinbiochem.2019.08.004. Epub 2019 Aug 3. Clin Biochem. 2019. PMID: 31386833 Clinical Trial.

6

Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients.

Hasegawa S, Nakamura S, Sugiura T, Tsuka Y, Takahashi N, Matsumura K, Okumiya T, Baden M, Shiojima I. Hasegawa S, et al. Among authors: okumiya t. BMC Nephrol. 2021 Dec 12;22(1):413. doi: 10.1186/s12882-021-02623-4. BMC Nephrol. 2021. PMID: 34895154 Free PMC article.

7

Erythrocyte creatine as a marker of excessive erythrocyte destruction due to hypersplenism in patients with liver cirrhosis.

Jiao YF, Okumiya T, Saibara T, Kudo Y, Sugiura T. Jiao YF, et al. Among authors: okumiya t. Clin Biochem. 2001 Jul;34(5):395-8. doi: 10.1016/s0009-9120(01)00242-9. Clin Biochem. 2001. PMID: 11522277

8

Hemolysis causes a decrease in HbA1c level but not in glycated albumin or 1,5-anhydroglucitol level.

Kiniwa N, Okumiya T, Tokuhiro S, Matsumura Y, Matsui H, Koga M. Kiniwa N, et al. Among authors: okumiya t. Scand J Clin Lab Invest. 2019 Oct;79(6):377-380. doi: 10.1080/00365513.2019.1627577. Epub 2019 Jun 17. Scand J Clin Lab Invest. 2019. PMID: 31204512

9

Estimation of the hemoglobin glycation rate constant.

Kameyama M, Okumiya T, Tokuhiro S, Matsumura Y, Matsui H, Ono Y, Iwasaka T, Hiratani K, Koga M. Kameyama M, et al. Among authors: okumiya t. Sci Rep. 2021 Jan 13;11(1):986. doi: 10.1038/s41598-020-80024-7. Sci Rep. 2021. PMID: 33441732 Free PMC article.

10

Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study.

Matsumura K, Okumiya T, Sugiura T, Takahashi N, Yamamoto Y, Kikuchi S, Fujii K, Otagaki M, Shiojima I. Matsumura K, et al. Among authors: okumiya t. BMC Nephrol. 2020 Sep 29;21(1):418. doi: 10.1186/s12882-020-02078-z. BMC Nephrol. 2020. PMID: 32993543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters